High Tide Gets Boost from Subsidiary's Expansion — Company Talk
High Tide's German medical cannabis subsidiary Remexian distributed a record 10.2 tons of product in fiscal third quarter 2026, up 62% from a year earlier. The segment generated record revenue of $38.2 million with gross margin of 26%. Since High Tide acquired its majority stake, Remexian's market…